FOI release

PAR for PL17736/0084

Some or all of the information requested was not provided because we didn't hold it.

Case reference FOI2025/01137

Received 27 October 2025

Published 4 December 2025

Request

The applicant would like to request for Public Assessment Report for PL17736/0084-Mebeverine 50mg/5ml Sugar Free Oral Suspension.

Response

See attached

Documents

• FOI2025_01137 (redacted).pdf (461.6 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.